Prenuvo opens its 200,000 scans - the screening dataset becomes a research network
20th October 2026
Prenuvo has launched a Research Network giving more than 50 institutions - City of Hope, UCSF and Moffitt Cancer Center among them - access to its Imaging Biobank of more than 200,000 whole-body MRI scans, which the company describes as the largest dataset of its kind. Four opening studies include a brain study of more than 78,000 people who chose a preventive scan, in which 7 in 100 showed a clinically significant abnormality such as an aneurysm, infarct or meningioma, and a kidney study covering 117,826 scans, in which the vast majority of findings were small and likely benign.
Key takeaways:
- The asset is the dataset: a cash-pay screening business is converting its scan archive into research infrastructure, at a moment when the company notes US NIH competitive grant awards have fallen sharply in fiscal 2026
- The population is self-selected: these are people who chose and paid to be scanned, not a random sample, so finding rates do not read across to the general public
- Finding is not the same as helping: the company’s own studies call for prospective research on lung cancer mortality, on how incidental brain findings are managed afterwards, and on frameworks to triage kidney findings at scale
Hype check: Proven - the network, the 50-plus collaborators and the reported finding rates in Prenuvo’s own self-selected scan population. Promising - a biobank of this scale revealing early signs of ageing and disease that smaller datasets cannot show. Marketing - the largest-dataset-in-medicine framing is company language, and no evidence yet shows that scanning this population improves health outcomes; that is the research question, not the result.